| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.00074 | 1 |